Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Craig Miller currently holds 9,412 shares of Karuna Therapeutics, Inc. (KRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Craig Miller has been a net seller of KRTX stock. They have purchased $0 and sold $44.5M worth of shares.
Andrew Craig Miller's most recent insider trade was on Mar 18, 2024, when they sold 66,900 shares at $198.36 per share.
Andrew Craig Miller serves as Executive at Karuna Therapeutics, Inc. (KRTX). They have executed 106 insider transactions totaling $44.5M over their tenure at the company.
Andrew Craig Miller holds the position of Executive at Karuna Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Andrew Craig Miller has shown a selling trading pattern, with $0 in total purchases and $44.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew Craig Miller was on Mar 18, 2024, when they sold $74.4M worth of KRTX shares. This transaction involved 231,992 shares at $320.80 per share.
Andrew Craig Miller currently owns 9,412 shares of Karuna Therapeutics, Inc. (KRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Craig Miller's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Craig Miller has 106 Form 4 filings on record as an insider at Karuna Therapeutics, Inc..
Set alerts for Andrew Craig Miller and 40,000+ other insiders.